766 Service Road, East Lansing, MI 48824 phpinfo@msu.edu

 

Xiaoqun Dong is an Assistant Professor in the Precision Health Program. She received her MD degree in Medicine, Master in Hematology and Oncology, and PhD in Genetics from Chinese Academy of Medical Sciences (CAMS) and Peking Union Medical College (PUMC), Tsinghua University. She received her postdoctoral fellowship at the Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center.

 

Xiaoqun Dong

 

dongxi19@msu.edu

Research Interests:

  • Molecular Mechanisms Driving Tumorigenesis and Metastasis
  • Cancer Diagnostics and Prognostics
  • Cancer Targeted Therapy and Immunotherapy
 
Achievements

Awards

  • 2008    The University of Texas MD Anderson Cancer Center: First Place for Bayer HealthCare Pharmaceuticals, Inc. Award in Population/Patient-Oriented Research for Trainee Research Day
  • 2009    The University of Texas MD Anderson Cancer Center: Poster Finalist for Bayer HealthCare Pharmaceuticals, Inc. Award in Population/Patient-Oriented Research for Trainee Research Day
  • 2010    The University of Texas MD Anderson Cancer Center: Poster Finalist for Bayer HealthCare Pharmaceuticals, Inc. Award in Population/Patient-Oriented Research for Trainee Research Day
  • 2011    AACR-FNAB Fellows Grant for Translational Pancreatic Cancer Research
  • 2011    Khalifa Bin Zayed Al Nahyan Foundation Award


Patents

  • Provisional Application: Inhibition of ASPH expressing tumor growth and progression. Inventors: Jack R. Wands, Xiaoqun Dong; International Application No. PCT/US2019/066174; International Filing Date 13.12.2019; Publication Number WO/2020/123912; Publication Date 18.06.2020; Publication Number CA3123006; EP3893925; KR1020210129634; CN113747914; JP2022512384; US20220054614
  • U.S. Provisional Application: DIAGNOSIS, PROGNOSIS AND TREATMENT OF MALIGNANT NEOPLASMS. Inventors: Jack R. Wands, Rolf I. Carlson, Xiaoqun Dong; PCT International Application No.: PCT/US2023/70963; Filing Date: July 25, 2023


Editorial Board

  • Cancer Letters
  • American Journal of Cancer Research (AJCR)
  • Scientific Reports – Nature
  • International Journal of Molecular Sciences (Guest Editor)
  • Frontiers in Oncology (Editor, Guest Editor)


Invited Video Abstract

  • Dong X. Insulin-like Growth Factor Axis Gene Polymorphisms and Clinical Outcome in Pancreatic Cancer. Gastroenterology 2010; 139 (2). http://www.gastrojournal.org


News Press Release

  • ASCO (American Society of Clinical Oncology), MD Anderson Cancer Center News Press Release “Glitches in DNA Repair Genes Predict Prognosis in Pancreatic Cancer—MD Anderson study identifies gene variants that interact with known factors for the disease” in Mar. 2009.
  • “Genetic Variants Predict Survival in Pancreatic Cancer-Increasing number of mismatch repair gene polymorphisms linked to increased mortality” HealthDay News, OncoLink and ModernMedicine.
  • “Body Roundness Index and All-Cause Mortality Among US Adults”. JAMA Netw Open. 2024 Jun 3;7(6):e2415051. Interviews from New York Times, NBC News, Healthline, Le Figaro (France)

Dong Lab